Literature DB >> 7447799

Specular microscopy of irido-corneal endothelial syndrome.

L W Hirst, H A Quigley, W J Stark, N B Shields.   

Abstract

Clinical specular microscopic examination of 17 patients with features common to the irido-corneal endothelial syndrome (including Chandler's syndrome, iris nevus syndrome, and essential iris atrophy) revealed pathognomonic endothelial changes and no areas of normal endothelial mosaic. Even in those patients with minimal anterior synechiae, gross central endothelial changes could be found, suggesting that the endothelial changes are primary and not secondary to the iris-corneal adhesions. Specular microscopy of the clinically-uninvolved contralateral eye in the patients revealed frequent endothelial-cell pleomorphism incommensurate with the patient's age. This study also confirmed the value of the specular microscopy in making qualitative endothelial observations.

Entities:  

Mesh:

Year:  1980        PMID: 7447799     DOI: 10.1111/j.1442-9071.1980.tb01672.x

Source DB:  PubMed          Journal:  Aust J Ophthalmol        ISSN: 0310-1177


  4 in total

1.  Surgical outcomes of patients with iridocorneal endothelial syndrome: a case series.

Authors:  Serhat Imamoglu; Mehmet S Sevim; Hatice Elvin Yıldız; Ece Turan Vural; Handan Bardak; Yavuz Bardak
Journal:  Int Ophthalmol       Date:  2016-08-06       Impact factor: 2.031

2.  Unique variations and characteristics of iridocorneal endothelial syndrome in China: a case series of 58 patients.

Authors:  Bo Feng; Xin Tang; Hong Chen; Xia Sun; Ningli Wang
Journal:  Int Ophthalmol       Date:  2017-10-10       Impact factor: 2.031

Review 3.  Specular microscopy in clinical practice.

Authors:  Sunita Chaurasia; Murugesan Vanathi
Journal:  Indian J Ophthalmol       Date:  2021-03       Impact factor: 1.848

4.  Glaucoma associated with iridocorneal endothelial syndrome in 203 Indian subjects.

Authors:  Premanand Chandran; Harsha L Rao; Anil K Mandal; Nikhil S Choudhari; Chandra S Garudadri; Sirisha Senthil
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.